These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 1479727)

  • 21. Does MICA influence acute rejection in kidney transplantation?
    Kato M; Kinukawa T; Hattori R; Tsuji Y; Hirano A; Horie K; Tsuyuki M; Mizutani K
    Clin Transpl; 2006; ():389-93. PubMed ID: 18365394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction and treatment of recurrent focal segmental glomerulosclerosis after renal transplantation in children.
    Dall'Amico R; Ghiggeri G; Carraro M; Artero M; Ghio L; Zamorani E; Zennaro C; Basile G; Montini G; Rivabella L; Cardillo M; Scalamogna M; Ginevri F
    Am J Kidney Dis; 1999 Dec; 34(6):1048-55. PubMed ID: 10585314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recurrence of nephrotic proteinuria in children with focal segmental glomerulosclerosis after renal transplantation treated with plasmapheresis and immunoadsorption: case reports.
    Fencl F; Simková E; Vondrák K; Janda J; Chadimová M; Stejskal J; Seeman T
    Transplant Proc; 2007 Dec; 39(10):3488-90. PubMed ID: 18089416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Plasmapheresis in the combined treatment of the kidney transplant rejection crisis].
    Serniak PS; Kovalenko NV; Bogomolov AM; Zakharov VV; Chernobrivtsev PA
    Urol Nefrol (Mosk); 1989; (4):7-10. PubMed ID: 2800082
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of double-filtration plasmapheresis in combination with interferon and ribavirin in living donor liver transplant recipients with hepatitis C.
    Taniguchi M; Furukawa H; Shimamura T; Suzuki T; Yamashita K; Ota M; Todo S
    Transplantation; 2006 Jun; 81(12):1747-9. PubMed ID: 16794544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Plasmapheresis in the treatment of the acute reaction of transplanted kidney rejection].
    Eras Mederos A; Acosta Dominguez A; García Proveyer A; Ramos Alvarez F; Perez Oliva J
    Urol Nefrol (Mosk); 1989; (4):10-1. PubMed ID: 2800069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recurrence of focal glomerulosclerosis in post-renal transplant recipients: report of two cases.
    Akioka K; Okamoto M; Ushigome H; Kadotani Y; Ogino S; Higuchi A; Wakabayashi Y; Kaihara S; Yoshimura N
    Transplant Proc; 2004 Sep; 36(7):2167-8. PubMed ID: 15518788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Completely reversed acute rejection episodes do not influence the long-term renal allograft survival].
    Wu JY; Chen JH; Wang YM; Zhang JG; Zhu C; Wang SY; Zhang P; Huang HF; He Q
    Zhonghua Yi Xue Za Zhi; 2003 Jan; 83(2):106-9. PubMed ID: 12812676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Use of plasmapheresis in intensive therapy of acute steroid-resistant rejection reaction in renal transplants].
    Kazimirov VG; Perlin DV; Shcherbakova EO; Prokopenko EI; Nesterenko IV
    Anesteziol Reanimatol; 1998; (6):62-5. PubMed ID: 10050341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The rationale for plasmapheresis in renal graft rejection.
    Frascà G; Vangelista A; DiFelice A; D'Arcangelo GL; Sermasi G; Zucchelli P; Bonomini V
    Life Support Syst; 1984; 2(2):131-6. PubMed ID: 6384671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. OKT3 escalating dose regimens provide effective therapy for renal allograft rejection.
    Woodle ES; Bruce DS; Josephson M; Cronin D; Newell KA; Millis JM; Piper JB; O'Laughlin R; Thistlethwaite JR
    Clin Transplant; 1996 Aug; 10(4):389-95. PubMed ID: 8884115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors and outcome of focal and segmental glomerulosclerosis recurrence in adult renal transplant recipients.
    Pardon A; Audard V; Caillard S; Moulin B; Desvaux D; Bentaarit B; Remy P; Sahali D; Roudot-Thoraval F; Lang P; Grimbert P
    Nephrol Dial Transplant; 2006 Apr; 21(4):1053-9. PubMed ID: 16364987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of OKT3 therapy for acute rejection in isolated lung transplantation.
    Shennib H; Massard G; Reynaud M; Noirclerc M
    J Heart Lung Transplant; 1994; 13(3):514-9. PubMed ID: 8061029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A case report of double-filtration plasmapheresis for the resolution of refractory chronic urticaria.
    Jiang X; Lu M; Ying Y; Feng J; Ye Y
    Ther Apher Dial; 2008 Dec; 12(6):505-8. PubMed ID: 19140850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single dose of Rituximab plus plasmapheresis in an HIV patient with acute humoral kidney transplant rejection: a case report.
    Moscoso-Solorzano GT; Baltar JM; Seco M; López-Larrea C; Mastroianni-Kirsztajn G; Ortega F
    Transplant Proc; 2007 Dec; 39(10):3460-2. PubMed ID: 18089407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Case of anti-glomerular basement membrane antibody nephritis in a patient who was able to withdraw from dialysis and gave birth twice but underwent living renal transplantation due to progression to end-stage renal failure 15 years after onset].
    Iwamoto I; Naiki Y; Nose K; Akiyama T; Sakaguchi M; Matsuoka T; Samejima K; Hiroaki S; Funauchi M
    Nihon Jinzo Gakkai Shi; 2009; 51(8):1080-5. PubMed ID: 19999588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased factor XIII activity in a patient with subcutaneous bleeding after double filtration plasmapheresis.
    Seishima M; Shibuya Y; Kato G; Aoki T
    Ther Apher Dial; 2009 Jun; 13(3):229-31. PubMed ID: 19527471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma cell-rich acute rejection after renal transplantation in a patient with pyoderma gangrenosum: a case report.
    Horie K; Fujita T; Tsuyuki M; Nishio F; Watanabe T; Kanou Y; Kuzuya A; Sato M; Kinukawa T
    Clin Transplant; 2010 Jul; 24 Suppl 22():39-43. PubMed ID: 20590693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of steroid-resistant and recurrent acute cardiac transplant rejection with a short course of antibody therapy.
    Cantarovich M; Latter DA; Loertscher R
    Clin Transplant; 1997 Aug; 11(4):316-21. PubMed ID: 9267721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rituximab and chronic plasmapheresis therapy of nephrotic syndrome in renal transplantation patients with recurrent focal segmental glomerulosclerosis.
    Rodríguez-Ferrero M; Ampuero J; Anaya F
    Transplant Proc; 2009; 41(6):2406-8. PubMed ID: 19715934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.